The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease.

Timely detection of this 'minimal residual disease' is now considered critical towards mitigating risks of recurrence. Target-MRD offers personalized, ultra-sensit ive detection and monitoring of ...

The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease. LONDON and ...

SINGAPORE – Cordlife announced its cord blood banking service and human tissue banking service licences have been renewed by the Ministry of Health (MOH) for one year, with effect from Jan 14.

The moon is expected to turn an eerie blood-red above the skies of the U.S. in the coming months, due to a rare total lunar eclipse. Late on March 13 and in the early hours of March 14 this year ...